Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

ACADIA Pharmaceuticals Inc.

ACAD

Valuace

Růst

Zdraví

Cena

$ 22.35

-0.54 (-2.04%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	1,071.5	1,071.5	957.8	726.4	517.2	484.1	441.8	339.1	223.8	124.9	17.3	0.1	0.1	1.1	4.9	2.1	42.1
Cost of Revenues	89.0	89.0	81.8	45.7	10.2	19.1	20.6	19.6	18.3	13.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	982.5	982.5	876.0	680.7	507.1	465.0	421.2	319.5	205.5	111.8	12.9	0.1	0.1	1.1	4.9	2.1	42.1

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	284.0	278.6	264.6	244.3	259.6	250.4	242.0	205.8	231.0	211.7
Cost of Revenues	26.2	21.6	20.7	20.4	21.8	18.9	18.2	23.0	17.9	14.6
Gross Profit	257.8	257.0	243.8	223.9	237.8	231.5	223.7	182.9	213.2	197.1

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	0.0	351.6	361.6	239.4	319.1	240.4	187.2	149.2	99.3	73.9	60.6	26.7	18.8	17.3	20.6
Selling General & Admin Expenses	0.0	0.0	0.0	402.5	369.1	396.0	388.7	325.6	265.8	255.1	186.5	90.8	32.7	12.7	7.0	7.6	6.5
Depreciation & Amortization	8.8	0.0	15.9	5.6	2.0	3.3	2.9	2.8	3.0	2.7	1.8	0.6	0.2	0.1	0.1	0.3	0.6
Total Operating Expenses	877.7	877.7	645.2	754.1	730.7	635.4	707.8	566.0	452.9	404.3	285.7	164.7	93.4	39.4	25.8	24.9	27.0
Operating Income	104.8	104.8	230.8	-73.4	-223.6	-170.4	-286.6	-246.5	-247.4	-292.4	-272.8	-164.6	-93.2	-38.3	-20.9	-22.9	15.1

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.7	157.0
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.5	97.9
Depreciation & Amortization	0.0	3.0	2.9	3.0	5.2	0.0	2.6	5.5	1.6	1.8
Total Operating Expenses	240.4	221.2	211.5	204.6	84.3	199.9	193.3	167.7	178.2	254.9
Operating Income	17.4	35.8	32.4	19.3	153.5	31.6	30.4	15.2	34.9	-57.8

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	31.7	31.7	25.5	17.2	6.6	0.6	6.6	11.2	5.3	4.1	2.8	0.5	0.8	0.3	0.0	0.0	0.1
Interest Expense	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Expense	34.1	34.1	27.3	22.3	10.2	2.9	5.6	12.2	-1.8	4.1	2.8	0.5	0.8	0.3	0.0	0.1	0.0
IBT	138.9	138.9	258.1	-51.0	-213.4	-167.5	-281.0	-234.4	-243.9	-288.3	-270.1	-164.1	-92.5	-37.9	-20.8	-22.8	15.1
Income Tax Expense	-252.1	-252.1	31.6	10.3	2.5	0.4	0.6	0.9	1.3	1.1	1.3	0.3	-0.2	0.0	-0.1	0.0	0.0
Net Income	391.0	391.0	226.5	-61.3	-216.0	-167.9	-281.6	-235.3	-245.2	-289.4	-271.4	-164.4	-92.5	-37.9	-20.8	-22.8	15.1

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	8.3	8.2	7.2	7.9	7.0	6.6	6.4	5.5	4.8	4.1
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Expense	8.9	8.8	7.8	8.5	7.6	7.2	6.7	5.8	4.8	5.6
IBT	26.3	44.6	40.2	27.8	161.1	38.8	37.2	21.0	39.7	-52.1
Income Tax Expense	-247.2	-27.2	13.5	8.8	17.3	6.0	3.8	4.4	-6.1	13.0
Net Income	273.6	71.8	26.7	19.0	143.7	32.8	33.4	16.6	45.8	-65.2

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$-0.37	$-1.34	$-1.05	$-1.79	$-1.60	$-1.94	$-2.36	$-2.34	$-1.63	$-0.95	$-0.44	$-0.38	$-0.44	$0.39
EPS Diluted	$0.00	$0.00	$0.00	$-0.37	$-1.34	$-1.05	$-1.79	$-1.60	$-1.94	$-2.36	$-2.34	$-1.63	$-0.95	$-0.44	$-0.38	$-0.44	$0.39
Shares Outstanding	169.3	169.3	165.7	163.8	161.7	160.5	157.3	147.2	126.6	122.6	115.9	100.6	97.2	85.7	55.1	52.2	38.6
Diluted Shares Outstanding	171.4	171.4	166.4	163.8	161.7	160.5	157.3	147.2	126.6	122.6	115.9	100.6	97.2	85.7	55.1	52.2	38.7

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.28	$-0.40
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.28	$-0.40
Shares Outstanding	169.3	168.8	167.8	166.8	166.5	166.0	165.6	164.8	164.8	164.2
Diluted Shares Outstanding	171.4	170.7	168.7	167.7	166.4	166.2	166.2	166.6	166.5	164.2

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	177.1	319.6	188.7	114.8	147.4	326.0	189.7	134.8	69.4	163.6	102.1	61.9	11.7	57.9	6.9	6.8
Short Term Investments	323.8	436.4	250.2	302.0	373.3	305.9	507.7	338.8	271.9	365.4	113.0	260.6	174.1	50.1	24.2	30.2
Total Cash & ST Investments	500.9	756.0	438.9	416.8	520.7	632.0	697.4	473.5	341.3	529.0	215.1	322.5	185.8	108.0	31.0	37.1
Accounts Receivable	110.4	104.7	102.4	63.1	65.3	50.3	37.9	27.8	18.4	7.1	1.6	1.0	0.0	0.0	0.0	0.0
Inventory	71.5	21.9	35.8	6.6	7.9	9.7	6.3	4.1	5.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	46.1	55.7	39.1	21.4	23.9	25.7	18.6	20.7	8.5	7.5	2.2	1.2	2.6	0.6	0.9	0.8
Total Current Assets	728.9	938.3	616.1	507.9	617.8	717.6	760.3	526.1	373.5	547.9	219.0	324.6	188.4	108.5	31.9	37.8

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	258.0	253.6	217.7	319.6	155.1	177.1	204.7	188.7	98.2	107.9
Short Term Investments	589.0	508.4	463.9	436.4	410.2	323.8	265.8	250.2	247.7	267.4
Total Cash & ST Investments	847.0	762.0	681.6	756.0	565.3	500.9	470.5	438.9	345.9	375.4
Accounts Receivable	139.4	119.7	113.7	104.7	98.2	110.4	100.1	102.4	94.5	84.2
Inventory	29.1	26.1	22.9	21.9	61.0	71.5	61.9	35.8	20.8	9.2
Other Current Assets	60.9	52.7	52.7	55.7	63.7	46.1	42.8	39.1	77.6	23.9
Total Current Assets	1,076.4	960.6	870.9	938.3	788.3	728.9	675.3	616.1	499.2	492.6

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	56.5	50.8	56.5	61.6	66.3	56.4	12.7	3.3	2.7	3.1	2.2	0.6	0.6	0.0	0.2	0.4
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	107.9	119.8	65.5	0.0	0.0	1.1	2.6	4.1	5.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	5.8	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	15.0	78.9	5.1	18.3	16.0	7.4	7.6	6.7	2.8	3.2	0.7	0.3	0.2	0.0	0.0	0.1
Total Long-Term Assets	185.2	249.4	132.8	79.9	82.3	65.0	22.9	14.1	11.0	13.3	2.9	0.8	0.8	0.0	0.2	0.5
Total Assets	914.1	1,187.8	749.0	587.8	700.1	782.6	783.2	540.2	384.5	561.2	221.9	325.5	189.1	108.6	32.1	38.4

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	53.4	54.5	54.1	50.8	48.2	56.5	58.7	56.5	55.6	57.6
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	111.6	114.3	117.1	119.8	105.5	107.9	110.2	65.5	66.9	68.2
Long-Term Investments	9.5	9.5	0.0	0.0	0.0	5.8	5.8	5.8	5.8	8.1
Other Long-Term Assets	79.9	86.7	90.3	78.9	34.8	15.0	5.2	5.1	10.9	24.3
Total Long-Term Assets	254.3	265.0	261.4	249.4	188.6	185.2	179.8	132.8	133.4	150.1
Total Assets	1,330.8	1,225.6	1,132.4	1,187.8	976.9	914.1	855.1	749.0	632.5	642.8

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	19.9	16.2	17.5	12.7	6.9	8.5	7.2	3.2	8.8	3.9	1.7	2.0	0.4	1.4	2.0	2.0
Short-Term Debt	10.5	10.0	9.4	9.3	8.3	5.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Other Current Liabilities	299.0	356.7	225.7	103.6	80.9	92.4	64.2	56.4	40.2	36.0	20.2	13.8	6.6	4.1	3.5	3.2
Current Liabilities	337.9	394.9	254.3	125.6	96.1	106.0	74.8	59.6	49.0	42.6	21.9	15.8	7.0	5.9	6.2	6.0

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	21.7	20.1	18.1	16.2	19.1	19.9	19.3	17.5	12.3	18.8
Short-Term Debt	11.8	11.7	11.4	10.0	8.9	10.5	10.5	9.4	9.0	9.1
Other Current Liabilities	323.1	298.2	264.0	356.7	315.9	299.0	293.2	225.7	179.8	160.1
Current Liabilities	356.6	330.0	302.5	394.9	343.9	337.9	330.6	254.3	209.6	187.9

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	47.2	42.0	47.8	52.7	56.1	44.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases	47.2	52.0	57.2	52.7	56.1	44.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	397.4	455.0	317.2	187.4	159.2	155.6	84.0	61.1	49.2	42.7	22.1	16.0	7.0	23.6	8.8	8.7

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	43.0	44.6	44.6	42.0	40.4	47.2	49.2	47.8	96.2	99.6
Capital Leases	0.0	0.0	56.0	52.0	49.4	47.2	49.2	47.8	48.1	49.8
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	413.5	403.2	367.1	455.0	399.7	397.4	391.1	317.2	270.4	247.0

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-2,380.9	-2,204.4	-2,430.8	-2,369.6	-2,153.6	-1,985.7	-1,704.1	-1,468.9	-1,223.7	-934.0	-662.6	-498.1	-405.7	-367.7	-346.9	-324.1
Comprehensive Income	-0.3	0.3	0.0	-1.0	-0.2	0.0	0.3	-0.4	-0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5
Total Common Equity	516.7	732.8	431.8	400.4	540.9	627.0	699.1	479.1	335.3	518.4	199.8	309.5	182.1	85.0	23.4	29.7

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-2,087.0	-2,158.7	-2,185.4	-2,204.4	-2,348.1	-2,380.9	-2,414.3	-2,430.8	-2,476.6	-2,411.5
Comprehensive Income	1.0	0.4	0.4	0.3	0.9	-0.3	-0.2	0.0	-0.3	-0.5
Total Common Equity	917.3	822.4	765.2	732.8	577.2	516.7	464.0	431.8	362.2	395.8

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		57.7	52.0	57.2	62.0	56.1	44.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Book Value		516.7	732.8	431.8	400.4	540.9	627.0	699.1	479.1	335.3	518.4	199.8	309.5	182.1	85.0	23.4	29.7

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		917.3	822.4	765.2	732.8	577.2	516.7	464.0	431.8	362.2	395.8

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	30.6	391.0	226.5	-61.3	-216.0	-167.9	-281.6	-235.3	-245.2	-289.4	-271.4	-164.4	-92.5	-37.9	-20.8	-22.8	15.1
Depreciation & Amortization	11.5	11.8	15.9	5.6	2.0	3.3	2.9	2.8	3.0	2.7	1.8	0.6	0.2	0.1	0.1	0.3	0.6
Stock-Based Compensation	67.0	0.0	67.0	66.4	68.2	63.6	84.4	82.3	81.6	75.5	55.3	40.2	16.0	5.7	1.9	1.6	1.6
Change Working Capital	-19.5	-89.8	4.2	18.1	38.0	-24.8	11.0	3.7	-8.2	-6.4	4.4	4.1	9.3	-1.1	-2.4	0.1	-27.8
Change In Accounts Receivable	-25.5	-43.5	-2.3	-39.3	2.2	-16.1	-12.5	-9.7	-8.7	-11.4	-5.9	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	1.1	-5.3	-1.4	4.8	5.9	-1.6	1.3	4.1	-5.6	4.9	2.2	-0.3	1.6	-1.0	-0.6	0.0	-1.0
Change In Inventories	-70.1	-18.2	-49.6	-28.8	2.4	-4.2	-3.3	-1.7	1.9	-1.0	-3.3	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	176.1	46.7	-155.8	-12.1	-6.3	0.1	44.3	-4.6	1.4	-0.3	0.1	-2.1	0.5	1.5	-0.4	0.8	-0.2
Cash from Operations	80.5	0.0	0.0	16.7	-114.0	-125.7	-136.2	-151.1	-167.5	-217.9	-210.4	-121.8	-66.4	-31.8	-21.6	-19.9	-10.7

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	273.6	71.8	26.7	19.0	143.7	32.8	33.4	16.6	45.8	-65.2
Depreciation & Amortization	2.9	3.0	-1.2	3.0	5.2	2.6	2.6	5.5	1.6	1.7
Stock-Based Compensation	0.0	13.2	14.3	11.4	10.5	26.2	15.7	14.8	18.0	18.5
Change Working Capital	-87.9	-12.5	21.6	-10.9	30.3	4.5	-24.7	-6.0	21.7	-10.6
Change In Accounts Receivable	-8.8	-19.7	-6.0	-9.0	5.7	0.0	-10.3	2.3	-7.8	-11.0
Change In Accounts Payable	-10.8	1.7	2.0	1.9	-2.9	-0.8	0.6	1.8	5.2	-6.5
Change In Inventories	-4.9	1.2	-4.1	-10.5	-4.4	-1.3	-27.1	-16.6	-15.1	-11.2
Other Non-cash Items	12.6	-1.1	2.6	-2.1	-149.3	-2.7	-2.0	-1.8	37.2	46.6
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.4	-59.0

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	-0.1	-103.5	-0.5	-40.1	0.0	-1.1	-7.6	-1.1	-2.1	-0.8	-9.5	-2.1	-0.2	-0.6	0.0	0.0	0.0
Acquisitions	0.1	0.0	0.0	-32.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	-2.1	0.0	0.0	0.0	0.0	0.0
Investments	-359.2	-692.6	-505.1	-370.0	-363.2	-492.8	-339.9	-578.6	-331.1	-478.8	-683.4	-269.5	-335.4	-211.6	-56.7	-48.1	-54.7
Sales of Investment	322.7	493.5	328.6	442.0	436.4	422.8	540.0	413.9	261.7	572.1	430.9	419.2	248.3	86.1	30.9	54.0	53.5
Other Investing Activities	-70.6	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.0	2.1	0.0	0.0	0.3	0.0	0.1
Cash from Investing	-36.5	0.0	0.0	32.0	73.2	-71.1	192.5	-165.8	-71.5	92.5	-261.9	147.6	-87.3	-126.1	-25.5	6.0	-1.1

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-4.0	-0.4	98.5	-98.8	-0.5	-0.1	0.0	0.0	0.0	-0.1
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Investments	-157.6	-204.6	-174.4	-156.0	-135.8	-151.5	-137.7	-80.2	-104.1	-37.2
Sales of Investment	105.8	125.6	131.4	130.8	111.9	69.1	81.5	66.1	103.8	71.4
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	-0.1
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	34.1

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	-0.4
Debt Issued	7.9	52.0	-5.2	-4.8	5.9	11.7	38.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5
Issuance of Common Stock	22.8	0.0	0.0	25.1	8.2	18.2	81.0	371.8	306.6	31.2	518.9	14.5	203.9	111.7	98.2	14.0	0.8
Repurchase of Common Stock	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Financing	22.8	0.0	0.0	25.1	8.2	18.2	81.0	371.8	306.6	31.2	533.8	14.5	203.9	111.7	98.2	13.9	0.5

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	54.8	-1.5	0.3	4.0	2.6	-8.3	-2.0	2.4	9.1	-1.7
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.8
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.8

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		66.8	-141.9	133.9	73.8	-32.6	-178.6	137.3	54.9	67.7	-94.2	61.5	40.3	50.1	-46.2	51.0	0.0	-11.3
Closing Cash Balance		177.1	177.7	328.4	188.7	120.6	153.2	331.8	194.5	139.6	69.4	163.6	102.1	61.9	11.7	57.9	6.9	6.8

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-80.3	4.4	36.6	-101.9	164.4	-19.0	-27.6	16.1	90.5	-12.1
Closing Cash Balance		177.7	267.5	263.1	226.5	328.4	163.9	182.9	210.5	188.7	104.0

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		80.5	105.1	157.2	-23.3	-114.0	-126.8	-143.8	-152.3	-169.6	-218.7	-219.9	-123.9	-66.6	-32.4	-21.6	-19.9	-10.7
Real Free Cash Flow		13.5	105.1	90.1	-89.8	-182.2	-190.4	-228.2	-234.5	-251.2	-294.2	-275.2	-164.1	-82.7	-38.1	-23.6	-21.5	-12.3

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-52.7	73.9	162.5	-78.5	39.9	63.2	25.0	29.1	85.4	-59.0
Real Free Cash Flow		-52.7	60.7	148.2	-89.9	29.5	37.0	9.3	14.3	67.4	-77.5